## ALL: Allstate Corporation (The) - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.23 indicates fundamental undervaluation. Quality metrics strong (ROE 34%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($199.94)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Allstate Corp (ALL) Leads Bank of America's Top Growth Stocks**
- Source: GuruFocus | 20251210T172928 | Somewhat-Bullish | Relevance: 90%
- Allstate Corp. (ALL) has been identified by Bank of America as a top growth stock, projecting an 18.9% EPS growth over the next five years and earning a strong buy rating from Seeking Alpha's Quant metrics. While the company boasts strong financial health with high revenue growth and profitability, potential investors should be mindful of insider selling activity and mixed valuation signals. Allstate, a prominent property-casualty insurer, demonstrates robust financial metrics but also presents warning signs such as insider selling transactions without corresponding buying activity.

**2. 5 Top-Ranked Stocks From the Thriving P&C Insurance Industry for 2026**
- Source: Finviz | 20251210T070400 | Bullish | Relevance: 89%
- The Property & Casualty (P&C) insurance industry is poised for growth due to favorable pricing, improved underwriting, and increased exposure. This article highlights five top-ranked P&C insurers with a Zacks Rank #1 (Strong Buy): The Travelers Companies Inc. (TRV), RenaissanceRe Holdings Ltd. (RNR), The Allstate Corp. (ALL), Mercury General Corp. (MCY), and Heritage Insurance Holdings Inc. (HRTG). These companies are expected to benefit from strategic investments in technology, operational efficiency, and strong capital positions.

**3. Darsana Capital Partners LP Has $261.25 Million Stock Holdings in Liberty Media Corporation - Liberty Formula One Series C $FWONK**
- Source: MarketBeat | 20251212T100939 | Neutral | Relevance: 74%
- Darsana Capital Partners LP recently reduced its stake in Liberty Media â€” Formula One Series C (NASDAQ:FWONK) by 28.4%, now holding 2.5 million shares valued at $261.25 million, making it their 6th largest holding. Concurrently, company insiders have been net sellers, offloading over 201,000 shares worth approximately $20.55 million in the past three months. Despite missing EPS estimates, Liberty Media saw revenues slightly beat expectations and currently holds a "Moderate Buy" consensus rating from analysts with an average price target of $112.33.

**4. AtaiBeckley, OKYO Pharma, New Era Energy & Digital, Century Lithium featured in Friday's small cap wrap**
- Source: Proactive financial news | 20251211T150901 | Somewhat-Bullish | Relevance: 73%
- This article provides a small cap wrap-up featuring several companies and their recent developments. Key updates include Hazer Group's methane-pyrolysis technology selected by M Resources, OKYO Pharma's investigational therapy showing improvements in corneal nerve structure, and AtaiBeckley being granted a new patent for its R-MDMA formulation. Additionally, Century Lithium's Angel Island project revealed potentially significant rare earth elements, and New Era Energy & Digital made advances at its Texas Critical Data Centers campus.

**5. The top 10 insurance companies in the USA by market share**
- Source: Insurance Business | 20251212T180804 | Somewhat-Bullish | Relevance: 72%
- This article identifies the top 10 insurance companies in the USA by market share, providing detailed profiles of each, including their distinct features and financial standing. It serves as a comprehensive guide for brokers, agents, and policyholders to understand the leading carriers and make informed decisions. The piece also offers advice on how to choose the best insurance provider based on client needs and risk assessment.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | Roth Capital | $240 | $230 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | Roth Capital | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.12M) |
| Sells | 12 ($11.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (-0.3%)
- Blackrock Inc.: 8.5% (-1.0%)
- Price (T.Rowe) Assoc: 4.9% (-17.0%)
- State Street Corpora: 4.5% (+0.7%)
- Geode Capital Manage: 2.7% (+3.3%)

### Key Risks

1. Heavy insider selling: $11M sold (12 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.23 suggests fair value with growth premium. Quality metrics strong (ROE 34%). Balance sheet: strong liquidity (30938000000.0x), $3.2B free cash flow. Insider selling cluster ($11.2M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $54.6B |
| Beta | 0.25 |
| 52W Range | $176.00 - $215.89 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.23 |
| Forward P/E | 8.6 |
| Current P/E | 7.2 |
| YoY Growth | -15.9% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -6.0% to -1.1% (+4.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 5.1pp (needs >4.0% for momentum thesis). MRS_5 turning positive (3.2%) - potential reversal signal. Underperforming sector by 4.7pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). MACD histogram bearish (-0.84), momentum weakening. RSI neutral at 53. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.12% (CS: 29) | Neutral |
| RSI_14 | 52.8 | Neutral |
| MACD Histogram | -0.84 | Bearish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 1.026x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $207.18
- **Stop Loss:** $199.94 (3.5% risk)
- **Target:** $221.66 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 165
- **Position Value:** $34,184.70
- **Portfolio %:** 34.18%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-04 (Est: $8.25)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.54 | $11.17 | +48.1% |
| 2025Q2 | $3.26 | $5.94 | +82.4% |
| 2025Q1 | $2.53 | $3.53 | +39.3% |
| 2024Q4 | $6.28 | $7.67 | +22.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*